Affiliation:
1. Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts
2. Immunology Research Division, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts
Abstract
ABSTRACT
Campylobacter jejuni
continues to be a leading cause of bacterial enteritis in humans. However, because there are no readily available animal models to study the pathogenesis of
C. jejuni
-related diseases, the significance of potential virulence factors, such as cytolethal distending toxin (CDT), in vivo are poorly understood. Mice deficient in NF-κB subunits (p50
−/−
p65
+/−
) in a C57BL/129 background are particularly susceptible to colitis induced by another enterohepatic microaerobe,
Helicobacter hepaticus
, which, like
C. jejuni
, produces CDT. Wild-type
C. jejuni
81-176 and an isogenic mutant lacking CDT activity (
cdtB
mutant) were inoculated into NF-κB-deficient (3X) and C57BL/129 mice. Wild-type
C. jejuni
colonized 29 and 50% of the C57BL/129 mice at 2 and 4 months postinfection (p.i.), respectively, whereas the
C. jejuni cdtB
mutant colonized 50% of the C57BL/129 mice at 2 p.i. but none of the mice at 4 months p.i. Although the C57BL/129 mice developed mild gastritis and typhlocolitis, they had robust immunoglobulin G (IgG) and Th1-promoted IgG2a humoral responses to both the wild-type strain and the
C. jejuni cdtB
mutant. In contrast, 75 to 100% of the 3X mice were colonized with both the wild type and the
C. jejuni cdtB
mutant at similar levels at all times examined. Wild-type
C. jejuni
caused moderately severe gastritis and proximal duodenitis in 3X mice that were more severe than the gastrointestinal lesions caused by the
C. jejuni cdtB
mutant. Persistent colonization of NF-κB-deficient mice with the wild type and the
C. jejuni cdtB
mutant was associated with significantly impaired IgG and IgG2a humoral responses (
P
< 0.001), which is consistent with an innate or adaptive immune system defect(s). These results suggest that the mechanism of clearance of
C. jejuni
is NF-κB dependent and that CDT may have proinflammatory activity in vivo, as well as a potential role in the ability of
C. jejuni
to escape immune surveillance. NF-κB-deficient mice should be a useful model to further study the role of CDT and other aspects of
C. jejuni
pathogenesis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference46 articles.
1. Black, R. E., M. M. Levine, M. L. Clements, T. P. Hughes, and M. J. Blaser. 1988. Experimental Campylobacter jejuni infection in humans. J. Infect. Dis.157:472-479.
2. Bouzari, S., and A. Varghese. 1990. Cytolethal distending toxin (CLDT) production by enteropathogenic Escherichia coli (EPEC). FEMS Microbiol. Lett.59:193-198.
3. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus
4. Chien, C. C., N. S. Taylor, Z. Ge, D. B. Schauer, V. B. Young, and J. G. Fox. 2000. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J. Med. Microbiol.49:525-534.
5. Elwell, C. A., and L. A. Dreyfus. 2000. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol.37:952-963.
Cited by
164 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献